← Home
/
DAY ONE BIOPHARMACEUTICALS, INC. (DAWN)
Stock Analysis
DAY ONE BIOPHARMACEUTICALS, INC. (DAWN)
DAWN
DAWN · Market data
21.53
+0.00%
Updated: 2026-06-22 15:19 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 21.53. Holding above 18.81 keeps the current thesis intact.
✓
Fundamentals
Weak / Negative
✓
Price Structure
Constructive
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
18.81
↗
Break Above
Confirmation improves above resistance.
21.53
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 18.81
What's Driving DAWN?
📈 Technical recovery is improving
Momentum is Neutral. Watch 21.53 for confirmation and 18.81 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 18.81 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
📈 Net Income
-19.73M
↘ Negative
🧮 EPS (Basic)
-0.19
↘ Negative
DAY ONE BIOPHARMACEUTICALS, INC.
Note: This is an algorithmic technical snapshot, not financial advice.